Stimulation by TLR5 modulates osteoclast differentiation through STAT1/IFN-β1

Journal of Immunology

Volumn 180, Issue 3, 2008, Pages 1382-1389

  Ha, Hyunil ^a   Lee, Jong Ho ^a   Kim, Ha Neui ^a   Han, Bok Kwak ^a   Kim, Hyun Man ^a   Shee, Eun Lee ^b   Joon, Haeng Rhee ^b   Kim, Hong Hee ^a   Zang, Hee Lee ^a  

^a Seoul National University   (South Korea)

^b Chonnam National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTERFERON; FLAGELLIN; JANUS KINASE 2; LIPOPOLYSACCHARIDE; MESSENGER RNA; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; NEUTRALIZING ANTIBODY; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN C FOS; STAT1 PROTEIN; TOLL LIKE RECEPTOR 5; BETA INTERFERON; JAK2 PROTEIN, MOUSE; STAT1 PROTEIN, MOUSE; TICAM 1 PROTEIN, MOUSE; TICAM-1 PROTEIN, MOUSE; UNCLASSIFIED DRUG; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; DOWN REGULATION; GENE INDUCTION; INTERFERON PRODUCTION; MACROPHAGE; MALE; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CELL DIFFERENTIATION; COCULTURE; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; GENE EXPRESSION; GENETICS; METABOLISM; MOUSE MUTANT;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; FLAGELLIN; GENE EXPRESSION; INTERFERON-BETA; JANUS KINASE 2; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, MUTANT STRAINS; OSTEOCLASTS; PROTO-ONCOGENE PROTEINS C-FOS; RANK LIGAND; STAT1 TRANSCRIPTION FACTOR; TOLL-LIKE RECEPTOR 5;

EID: 40749100219     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.3.1382     Document Type: Article

References (52)

1. Lacey, D. L., E. Timms, H. L. Tan, M. J. Kelley, C. R. Dunstan, T. Burgess, R. Elliott, A. Colombero, G. Elliott, S. Scully, et al. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-176.
2. Jimi, E., S. Akiyama, T. Tsurukai, N. Okahashi, K. Kobayashi, N. Udagawa, T. Nishihara, N. Takahashi, and T. Suda. 1999. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J. Immunol. 163: 434-442.
3. Yoshida, H., S. Hayash, T. Kunisada, M. Ogawa, S. Nishikawa, H. Okamura, T. Sudo, L. D. Shultz, and S. Nishikawa. 1990. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345: 442-444.
4. Dai, X. M., G. R. Ryan, A. J. Hapel, M. G. Dominguez, R. G. Russell, S. Kapp, V. Sylvestre, and E. R. Stanley. 2002. Targeted disruption of the mouse colonystimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 99: 111-120.
5. Suda, T., N. Takahashi, N. Udagawa, E. Jimi, M. T. Gillespie, and T. J. Martin. 1999. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20: 345-357.
6. Boyle, W. J., W. S. Simonet, and D. L. Lacey. 2003. Osteoclast differentiation and activation. Nature 423: 337-342.
7. Lee, Z. H., and H. H. Kim. 2003. Signal transduction by receptor activator of nuclear factor κ B in osteoclasts. Biochem. Biophys. Res. Commun. 305: 211-214.
8. Grigoriads, A. E., Z. Q. Wang, M. G. Cecchini, R. Felix, H. A. Feisch, and E. F. Wagner. 1994. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266: 443-448.
9. Matsuo, K., J. M. Owens, M. Tonko, T. J. Chambers, and E. F. Wagner. 2000. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation. Nat. Genet. 24: 184-187.
10. Fleischmann, A., F. Hafezi, C. Elliott, C. E. Reme, U. Ruther, and E. F. Wagner. 2000. Fra-1 replaces c-Fos-dependent functions in mice. Genes Dev. 14: 2695-2700.
11. Takayanagi, H., S. Kim, T. Koga, H. Nishina, M. Isshiki, H. Yoshida, A. Saiura, M. Isobe, T. Yokochi, J. Inoue, et al. 2002. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3: 889-901.
12. Michelsen, K. S., T. M. Doherty, P. K. Shah, and M. Arditi. 2004. TLR signaling: an emerging bridge from innate immunity to atherogenesis. J. Immunol. 173: 5901-5907.
13. Beutler, B. 2004. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430: 257-263.
14. O'Neill, L. A. 2006. How Toll-like receptors signal: what we know and what we don't know. Curr. Opin. Immunol. 18: 3-9.
15. Smith, K. D., E. Andersen-Nissen, F. Hayashi, K. Strobe, M. A. Bergman, S. L. Barrett, B. T. Cookson, and A. Aderem. 2003. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat. Immunol. 4: 1247-1253.
16. Subramanian, N., and A. Qadri. 2006. Lysophospholipid sensing triggers secretion of flagellin from pathogenic salmonella. Nat. Immunol. 7: 583-589.
17. Nair, S. P., S. Meghji, M. Wilson, K. Reddi, P. White, and B. Henderson. 1996. Bacterially induced bone destruction: mechanisms and misconceptions. Infect. Immun. 64: 2371-2380.
18. Sato, N., N. Takahashi, K. Suda, M. Nakamura, M. Yamaki, T. Ninomiya, Y. Kobayashi, H. Takada, K. Shibata, M. Yamamoto, et al. 2004. MyD88 but not TRIF is essential for osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide, and IL-1α. J. Exp. Med. 200: 601-611.
19. Zou, W., A. Amcheslavsky, and Z. Bar-Shavit. 2003. CpG oligodeoxynucleotides modulate the osteoclastogenic activity of osteoblasts via Toll-like receptor 9. J. Biol. Chem. 278: 16732-16740.
20. Takami, M., N. Kim, J. Rho, and Y. Choi. 2002. Stimulation by toll-like receptors inhibits osteoclast differentiation. J. Immunol. 169: 1516-1523.
21. Lee, S. E., S. Y. Kim, B. C. Jeong, Y. R. Kim, S. J. Bae, O. S. Ahn, J. J. Lee, H. C. Song, J. M. Kim, H. E. Choy, et al. 2006. A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity. Infect. Immun. 74: 694-702.
22. Ha, H., J. H. Lee, H. N. Kim, H. M. Kim, H. B. Kwak, S. Lee, H. H. Kim, and Z. H. Lee. 2006. α-lipoic acid inhibits inflammatory bone resorption by suppressing prostaglandin E2 synthesis. J. Immunol. 176: 111-117.
23. Takayanagi, H., S. Kim, K. Matsuo, H. Suzuki, T. Suzuki, K. Sato, T. Yokochi, H. Oda, K. Nakamura, N. Ida, et al. 2002. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β. Nature 416: 744-749.
24. Mizel, S. B., A. N. Honko, M. A. Moors, P. S. Smith, and A. P. West. 2003. Induction of macrophage nitric oxide production by Gram-negative flagellin involves signaling via heteromeric Toll-like receptor 5/toll-like receptor 4 complexes. J. Immunol. 170: 6217-6223.
25. Yamamoto, M., S. Sato, H. Hemmi, K. Hoshino, T. Kaisho, H. Sanjo, O. Takeuchi, M. Sugiyama, M. Okabe, K. Takeda, et al. 2003. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301: 640-643.
26. Fitzgerald, K. A., S. M. McWhirter, K. L. Faia, D. C. Rowe, E. Latz, D. T. Golenbock, A. J. Coyle, S. M. Liao, and T. Maniatis. 2003. IKK- and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4: 491-496.
27. Hemmi, H., O. Takeuchi, S. Sato, M. Yamamoto, T. Kaisho, H. Sanjo, T. Kawai, K. Hoshino, K. Takeda, and S. Akira. 2004. The roles of two IκB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J. Exp. Med. 199: 1641-1650.
28. Hoebe, K., X. Du, P. Georgel, E. Janssen, K. Tabeta, S. O. Kim, J. Goode, P. Lin, N. Mann, S. Mudd, et al. 2003. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424: 743-748.
29. Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67: 227-264.
30. Taniguchi, T., K. Ogasawara, A. Takaoka, and N. Tanaka. 2001. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19: 623-655.
31. Coelho, L. F., G. M. de Freitas Almeida, F. J. Mennechet, A. Blangy, and G. Uze. 2005. Interferon-α and -β differentially regulate osteoclastogenesis: role of differential induction of chemokine CXCL11 expression. Proc. Natl. Acad. Sci. USA 102: 11917-11922.
32. Zheng, H., X. Yu, P. Collin-Osdoby, and P. Osdoby. 2006. RANKL stimulates inducible nitric-oxide synthase expression and nitric oxide production in developing osteoclasts: an autocrine negative feedback mechanism triggered by RANKL-induced interferon-β via NF-κB that restrains osteoclastogenesis and bone resorption. J. Biol. Chem. 281: 15809-15820.
33. Darnell, J. E., Jr. 1997. STATs and gene regulation. Science 277: 1630-1635.
34. Decker, T., and P. Kovarik. 2000. Serine phosphorylation of STATs. Oncogene 19: 2628-2637.
35. Simonet, W. S., D. L. Lacey, C. R. Dunstan, M. Kelley, M. S. Chang, R. Luthy, H. Q. Nguyen, S. Wooden, L. Bennett, T. Boone, et al. 1997. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89: 309-319.
36. Yasuda, H., N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, S. Mochizuki, A. Tomoyasu, K. Yano, M. Goto, A. Murakami, et al. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis- inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA 95: 3597-3602.
37. Wei, S., M. W. Wang, S. L. Teitelbaum, and F. P. Ross. 2002. Interleukin-4 reversibly inhibits osteoclastogenesis via inhibition of NF-κB and mitogen-activated protein kinase signaling. J. Biol. Chem. 277: 6622-6630.
38. Miyamoto, T., O. Ohneda, F. Arai, K. Iwamoto, S. Okada, K. Takagi, D. M. Anderson, and T. Suda. 2001. Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood 98: 2544-2554.
39. Takayanagi, H., K. Ogasawara, S. Hida, T. Chiba, S. Murata, K. Sato, A. Takaoka, T. Yokochi, H. Oda, K. Tanaka, et al. 2000. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ. Nature 408: 600-605.
40. Ruocco, M. G., S. Maeda, J. M. Park, T. Lawrence, L. C. Hsu, Y. Cao, G. Schett, E. F. Wagner, and M. Karin. 2005. IκB kinase (IKK)β, but not IKKα, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss. J. Exp. Med. 201: 1677-1687.
41. Lam, J., S. Takeshita, J. E. Barker, O. Kanagawa, F. P. Ross, and S. L. Teitelbaum. 2000. TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J. Clin. Invest. 106: 1481-1488.
42. Sun, L., Y. Peng, A. C. Sharrow, J. Iqbal, Z. Zhang, D. J. Papachristou, S. Zaidi, L. L. Zhu, B. B. Yaroslavskiy, H. Zhou, et al. 2006. FSH directly regulates bone mass. Cell 125: 247-260.
43. Honda, K., H. Yanai, A. Takaoka, and T. Taniguchi. 2005. Regulation of the type I IFN induction: a current view. Int. Immunol. 17: 1367-1378.
44. Wietek, C., S. M. Miggin, C. A. Jefferies, and L. A. O'Neill. 2003. Interferon regulatory factor-3-mediated activation of the interferon-sensitive response element by Toll-like receptor (TLR) 4 but not TLR3 requires the p65 subunit of NF-κB. J. Biol. Chem. 278: 50923-50931.
45. Rhee, S. H., A. C. Keates, M. P. Moyer, and C. Pothoulakis. 2004. MEK is a key modulator for TLR5-induced interleukin-8 and MIP3α gene expression in nontransformed human colonic epithelial cells. J. Biol. Chem. 279: 25179-25188.
46. Yu, Y., H. Zeng, M. Vijay-Kumar, A. S. Neish, D. Merlin, S. V. Sitaraman, and A. T. Gewirtz. 2004. STAT signaling underlies difference between flagellininduced and tumor necrosis factor-α-induced epithelial gene expression. J. Biol. Chem. 279: 35210-35218.
47. Gao, J., D. C. Morrison, T. J. Parmely, S. W. Russell, and W. J. Murphy. 1997. An interferon-γ-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-α and lipopolysaccharide. J. Biol. Chem. 272: 1226-1230.
48. Morita, R., T. Uchiyama, and T. Hori. 2005. Nitric oxide inhibits IFN-α production of human plasmacytoid dendritic cells partly via a guanosine 3′,5′-cyclic monophosphate-dependent pathway. J. Immunol. 175: 806-812.
49. Hayashi, S. I., T. Yamada, M. Tsuneto, T. Yamane, M. Takahashi, L. D. Shultz, and H. Yamazaki. 2003. Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-α. J. Immunol. 171: 5130-5139.
50. Roy, C. R., and D. S. Zamboni. 2006. Cytosolic detection of flagellin: a deadly twist. Nat. Immunol. 7: 549-551.
51. Franchi, L., A. Amer, M. Body-Malapel, T. D. Kanneganti, N. Ozoren, R. Jagirdar, N. Inohara, P. Vandenabeele, J. Bertin, A. Coyle, et al. 2006. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1β in salmonella-infected macrophages. Nat. Immunol. 7: 576-582.
52. Miao, E. A., C. M. Alpuche-Aranda, M. Dors, A. E. Clark, M. W. Bader, S. I. Miller, and A. Aderem. 2006. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1β via Ipaf. Nat. Immunol. 7: 569-575.